Gelonghui September 8th | On September 5th, CITIC Securities released a research report, covering Pharmacist Bang (9885.HK) for the first time and giving it a "buy" rating, optimistic about its sustainable profitability and development prospects. CITIC Securities pointed out in the research report that pharmacists helped deeply deploy the out-of-hospital sinking market, and their operating income increased from 6.06 billion yuan to 17.904 billion yuan from 2020 to 2024, with a compound growth rate of 31.1% during the period, with obvious scale advantages. In the self-operated business, the first launch of brands and the accelerated growth of the self-owned brand business led to the simultaneous increase in revenue and gross profit margin; The net margin of platform business commission rate and subsidy rate continues...
